Biophytis Short Interest Ratio and Short Volume

Biophytis (NASDAQ:BPTS) Short Interest Frequently Asked Questions

What is Biophytis' current short interest?

Short interest is the volume of Biophytis shares that have been sold short but have not yet been closed out or covered. As of December 31st, traders have sold 300 shares of BPTS short. Learn More on Biophytis' current short interest.

Is Biophytis' short interest increasing or decreasing?

Biophytis saw a decrease in short interest in December. As of December 31st, there was short interest totaling 300 shares, a decrease of 97.7% from the previous total of 13,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Biophytis' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Biophytis: Harrow Health, Inc. (3.86%), Aeglea BioTherapeutics, Inc. (2.04%), Citius Pharmaceuticals, Inc. (9.09%), Capstar Special Purpose Acquisition Corp. (0.99%), Aerovate Therapeutics, Inc. (2.62%), Verrica Pharmaceuticals Inc. (10.86%), Summit Therapeutics Inc. (2.05%), 9 Meters Biopharma, Inc. (3.09%), Fortress Biotech, Inc. (1.22%), and Epizyme, Inc. (6.06%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: S&P Global Inc. ($9.39 billion), Advanced Micro Devices, Inc. ($9.08 billion), Charter Communications, Inc. ($7.16 billion), Palo Alto Networks, Inc. ($4.05 billion), Lucid Group Inc ($3.43 billion), Wayfair Inc. ($3.11 billion), Rivian ($3.05 billion), Datadog, Inc. ($2.76 billion), Zscaler, Inc. ($2.55 billion), and Etsy, Inc. ($1.99 billion). View all of the most shorted stocks.

What does it mean to sell short Biophytis stock?

Short selling BPTS is an investing strategy that aims to generate trading profit from Biophytis as its price is falling. Biophytis' stock is trading down $0.20 today. To short Biophytis stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Biophytis will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Biophytis?

A short squeeze for Biophytis occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BPTS, which in turn drives the price of the stock up even further.

How often is Biophytis' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BPTS, twice per month. The most recent reporting period available is December, 31 2021.